Thailand mRNA Vaccines and RNAi Therapeutics Market (2025-2031) | Forecast, Segmentation, Companies, Growth, Analysis, Value, Industry, Share, Outlook, Trends, Size & Revenue, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Thailand mRNA Vaccines and RNAi Therapeutics Market - Industry Life Cycle

3.4 Thailand mRNA Vaccines and RNAi Therapeutics Market - Porter's Five Forces

3.5 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Administration, 2021 & 2031F

3.7 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for innovative healthcare solutions in Thailand

4.2.2 Rising prevalence of chronic diseases driving the need for advanced treatment options

4.2.3 Government initiatives and investments in healthcare infrastructure and research

4.3 Market Restraints

4.3.1 High costs associated with mRNA vaccines and RNAi therapeutics

4.3.2 Regulatory challenges and approval processes for new biotechnologies in Thailand

4.3.3 Limited awareness and understanding of mRNA vaccines and RNAi therapeutics among healthcare professionals and patients

6.1 Thailand mRNA Vaccines and RNAi Therapeutics Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Disease Type, 2021- 2031F

6.1.3 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Hereditary transthyretin-mediated amyloidosis genetic, 2021- 2031F

6.1.4 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Acute hepatic porphyria, 2021- 2031F

6.1.5 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Primary hyperoxaluria type 1, 2021- 2031F

6.1.6 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Atherosclerotic cardiovascular disease, 2021- 2031F

6.2 Thailand mRNA Vaccines and RNAi Therapeutics Market, By Administration

6.2.1 Overview and Analysis

6.2.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By IV infusion, 2021- 2031F

6.2.3 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3 Thailand mRNA Vaccines and RNAi Therapeutics Market, By End user

6.3.1 Overview and Analysis

6.3.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Research Institutes, 2021- 2031F

6.3.3 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F

7.1 Thailand mRNA Vaccines and RNAi Therapeutics Market Export to Major Countries

7.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Imports from Major Countries

8.1 Number of clinical trials and research studies conducted on mRNA vaccines and RNAi therapeutics in Thailand

8.2 Investment trends in biotechnology and pharmaceutical sectors in Thailand

8.3 Adoption rate of mRNA vaccines and RNAi therapeutics by healthcare facilities and practitioners in Thailand

9.1 Thailand mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Administration, 2021 & 2031F

9.3 Thailand mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F

10.1 Thailand mRNA Vaccines and RNAi Therapeutics Market Revenue Share, By Companies, 2024

10.2 Thailand mRNA Vaccines and RNAi Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters